- Home
- MNR vs RXRX Comparison
MNR vs RXRX Comparison
Compare MNR & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNR
- RXRX
- Stock Information
- Founded
- MNR 2017
- RXRX 2013
- Country
- MNR United States
- RXRX United States
- Employees
- MNR N/A
- RXRX N/A
- Industry
- MNR
- RXRX Biotechnology: Pharmaceutical Preparations
- Sector
- MNR
- RXRX Health Care
- Exchange
- MNR Nasdaq
- RXRX Nasdaq
- Market Cap
- MNR 2.0B
- RXRX 2.2B
- IPO Year
- MNR 2023
- RXRX 2021
- Fundamental
- Price
- MNR $12.06
- RXRX $4.20
- Analyst Decision
- MNR Strong Buy
- RXRX Buy
- Analyst Count
- MNR 4
- RXRX 4
- Target Price
- MNR $21.00
- RXRX $7.25
- AVG Volume (30 Days)
- MNR 391.0K
- RXRX 39.8M
- Earning Date
- MNR 11-06-2025
- RXRX 11-05-2025
- Dividend Yield
- MNR 23.18%
- RXRX N/A
- EPS Growth
- MNR N/A
- RXRX N/A
- EPS
- MNR 0.92
- RXRX N/A
- Revenue
- MNR $956,307,000.00
- RXRX $43,689,000.00
- Revenue This Year
- MNR $20.17
- RXRX $24.17
- Revenue Next Year
- MNR $34.33
- RXRX $20.96
- P/E Ratio
- MNR $12.84
- RXRX N/A
- Revenue Growth
- MNR 9.45
- RXRX N/A
- 52 Week Low
- MNR $11.39
- RXRX $3.79
- 52 Week High
- MNR $19.00
- RXRX $12.36
- Technical
- Relative Strength Index (RSI)
- MNR 48.02
- RXRX 34.48
- Support Level
- MNR $11.77
- RXRX $4.46
- Resistance Level
- MNR $12.18
- RXRX $4.80
- Average True Range (ATR)
- MNR 0.36
- RXRX 0.33
- MACD
- MNR 0.06
- RXRX -0.13
- Stochastic Oscillator
- MNR 79.07
- RXRX 11.44
About MNR Mach Natural Resources LP
Mach Natural Resources LP is an independent upstream oil and gas company. The company is focused on the acquisition, development and production of oil, natural gas, and NGL reserves in the Anadarko Basin region of Western Oklahoma, Southern Kansas, and the panhandle of Texas.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.